137 related articles for article (PubMed ID: 10519166)
1. Effects of cutaneous aspirin on the human stomach and duodenum.
Cryer B; Kliewer D; Sie H; McAllister L; Feldman M
Proc Assoc Am Physicians; 1999; 111(5):448-56. PubMed ID: 10519166
[TBL] [Abstract][Full Text] [Related]
2. Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans.
Cryer B; Feldman M
Gastroenterology; 1999 Jul; 117(1):17-25. PubMed ID: 10381905
[TBL] [Abstract][Full Text] [Related]
3. Comparison of salsalate and aspirin on mucosal injury and gastroduodenal mucosal prostaglandins.
Cryer B; Goldschmiedt M; Redfern JS; Feldman M
Gastroenterology; 1990 Dec; 99(6):1616-21. PubMed ID: 2227277
[TBL] [Abstract][Full Text] [Related]
4. Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial.
Feldman M; Cryer B; Mallat D; Go MF
Am J Gastroenterol; 2001 Jun; 96(6):1751-7. PubMed ID: 11419825
[TBL] [Abstract][Full Text] [Related]
5. Distribution of prostaglandins in gastric and duodenal mucosa of healthy subjects and duodenal ulcer patients: effects of aspirin and paracetamol.
Konturek SJ; Obtulowicz W; Sito E; Oleksy J; Wilkon S; Kiec-Dembinska A
Gut; 1981 Apr; 22(4):283-9. PubMed ID: 7239320
[TBL] [Abstract][Full Text] [Related]
6. Dose effects of aspirin on gastric prostaglandins and stomach mucosal injury.
Lee M; Cryer B; Feldman M
Ann Intern Med; 1994 Feb; 120(3):184-9. PubMed ID: 8273981
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase expression and prostanoid production in pyloric and duodenal mucosae in dogs after administration of nonsteroidal anti-inflammatory drugs.
Wooten JG; Blikslager AT; Ryan KA; Marks SL; Law JM; Lascelles BD
Am J Vet Res; 2008 Apr; 69(4):457-64. PubMed ID: 18380576
[TBL] [Abstract][Full Text] [Related]
8. Comparison of effects of calcium carbasalate and aspirin on gastroduodenal mucosal damage in human volunteers.
Murray FE; Hudson N; Atherton JC; Cole AT; Scheck F; Hawkey CJ
Gut; 1996 Jan; 38(1):11-4. PubMed ID: 8566836
[TBL] [Abstract][Full Text] [Related]
9. Co-administration of nitric oxide-aspirin (NCX-4016) and aspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans.
Fiorucci S; Mencarelli A; Meneguzzi A; Lechi A; Renga B; del Soldato P; Morelli A; Minuz P
J Am Coll Cardiol; 2004 Aug; 44(3):635-41. PubMed ID: 15358033
[TBL] [Abstract][Full Text] [Related]
10. Gastroduodenal mucosal damage with salsalate versus aspirin: results of experimental models and endoscopic studies in humans.
Scheiman JM; Elta GH
Semin Arthritis Rheum; 1990 Oct; 20(2):121-7. PubMed ID: 2123561
[TBL] [Abstract][Full Text] [Related]
11. [Comparison between effects of morning and evening administration of effervescent calcium carbasalate (equivalent of 160 mg aspirin) on the gastroduodenal mucosa in healthy volunteers].
Berlin I; Decroix D; Molinier P; Herrmann MA; Peraudeau P; Scheck F
Pathol Biol (Paris); 1997 Jun; 45(6):514-20. PubMed ID: 9309270
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of aspirin injury to human gastroduodenal mucosa.
Cohen MM; MacDonald WC
Prostaglandins Leukot Med; 1982 Aug; 9(2):241-55. PubMed ID: 6956930
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa.
Lanza FL; Royer GL; Nelson RS
N Engl J Med; 1980 Jul; 303(3):136-8. PubMed ID: 6966762
[No Abstract] [Full Text] [Related]
14. Increased gastroduodenal concentrations of transforming growth factor alpha in adaptation to aspirin in monkeys and rats.
Romano M; Lesch CA; Meise KS; Veljaca M; Sanchez B; Kraus ER; Boland CR; Guglietta A; Coffey RJ
Gastroenterology; 1996 May; 110(5):1448-55. PubMed ID: 8613050
[TBL] [Abstract][Full Text] [Related]
15. [Prostaglandin synthesis in stomach and duodenal mucosa of the human: effect of aspirin with and without antacid].
Stange EF; Preclik G; Gerber K; Fetzer G; Horn H; Schneider A; Ditschuneit H
Z Gastroenterol; 1987 Aug; 25 Suppl 3():162-5. PubMed ID: 3116776
[TBL] [Abstract][Full Text] [Related]
16. Effects of 24 hours of aspirin, Bufferin, paracetamol and placebo on normal human gastroduodenal mucosa.
Hoftiezer JW; O'Laughlin JC; Ivey KJ
Gut; 1982 Aug; 23(8):692-7. PubMed ID: 7095565
[TBL] [Abstract][Full Text] [Related]
17. Effect of allopurinol, sulphasalazine, and vitamin C on aspirin induced gastroduodenal injury in human volunteers.
McAlindon ME; Muller AF; Filipowicz B; Hawkey CJ
Gut; 1996 Apr; 38(4):518-24. PubMed ID: 8707080
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of the prostaglandins on the gastric mucosa.
Russell RI
Am J Med; 1986 Aug; 81(2A):2-4. PubMed ID: 3463208
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of gastric and duodenal damage and protection.
Hudson N; Hawthorne AB; Cole AT; Jones PD; Hawkey CJ
Hepatogastroenterology; 1992 Feb; 39 Suppl 1():31-6. PubMed ID: 1577394
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of enprostil against aspirin-induced gastroduodenal mucosal injury in man. Comparison with cimetidine and sucralfate.
Stiel D; Ellard KT; Hills LJ; Brooks PM
Am J Med; 1986 Aug; 81(2A):54-8. PubMed ID: 3092656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
